Patient-reported and economic outcomes related to sofosbuvir and ledipasvir treatment for chronic hepatitis C
{{output}}
We used published literature from 2013-2016, to review data regarding the new all oral interferon and ribavirin free direct acting antiviral (DAA's) treatment regimens. Areas covered: Specifically, this paper will address DAA's clinical efficacy, their associa... ...
